Abstract A039: Lower cellular activation of cMET signaling network is associated with reduced recurrence risk in stage II colorectal cancer

MLA

Fiona Ginty, et al. “Abstract A039: Lower Cellular Activation of CMET Signaling Network Is Associated with Reduced Recurrence Risk in Stage II Colorectal Cancer.” Molecular Cancer Therapeutics, vol. 18, Dec. 2019, p. A039. EBSCOhost, https://doi.org/10.1158/1535-7163.targ-19-a039.

APA

Fiona Ginty, Sanghee Cho, Anup Sood, Travis J. Hollmann, Jinru Shia, John Frederick Graf, Daniel B. Longley, Jochen H. M. Prehn, Philip D Dunne, Andreas U. Lindner, Mark Lawler, Elizabeth McDonough, & Manuela Salvucci. (2019). Abstract A039: Lower cellular activation of cMET signaling network is associated with reduced recurrence risk in stage II colorectal cancer. Molecular Cancer Therapeutics, 18, A039. https://doi.org/10.1158/1535-7163.targ-19-a039

Chicago

Fiona Ginty, Sanghee Cho, Anup Sood, Travis J. Hollmann, Jinru Shia, John Frederick Graf, Daniel B. Longley, et al. 2019. “Abstract A039: Lower Cellular Activation of CMET Signaling Network Is Associated with Reduced Recurrence Risk in Stage II Colorectal Cancer.” Molecular Cancer Therapeutics 18 (December): A039. doi:10.1158/1535-7163.targ-19-a039.